Related Experiment Video
Updated: Jan 10, 2026

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.5K
Nutraceuticals and neuroprotection for glaucoma-introducing the NP-10 System
Zhengyang Liu1,2,3,4, Ghee Soon Ang2,4
1Department of Ophthalmology, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia.
Therapeutic Advances in Ophthalmology
|November 24, 2025
Summary
Glaucoma can worsen despite controlled eye pressure, necessitating neuroprotection for retinal ganglion cells. The NP-10 System framework explores nutraceuticals to proactively support eye health and vision in glaucoma patients.
Area of Science:
- Ophthalmology
- Neuroscience
- Nutritional Science
Background:
- Glaucoma is a leading cause of irreversible blindness globally.
- Current glaucoma management is often reactive and lacks proactive neuroprotection.
- Retinal ganglion cell survival is critical, yet often compromised even with controlled intraocular pressure (IOP).
Purpose of the Study:
- To introduce the NP-10 System, a novel conceptual framework for glaucoma neuroprotection.
- To systematically address 10 interrelated neuroprotective mechanisms in glaucomatous neurodegeneration.
- To explore the potential of specific nutraceutical interventions in glaucoma management.
Main Methods:
- The NP-10 System categorizes neuroprotective mechanisms into pressure-related, vascular, cellular, and functional factors.
- Identified nutraceuticals include saffron, French maritime pine, bilberry, and others.
- These interventions are proposed to target multiple mechanisms simultaneously.
Main Results:
- Nutraceuticals may reduce IOP, modulate stress, and improve ocular perfusion.
- Potential benefits include enhanced cellular bioenergetics, antioxidant and anti-inflammatory effects.
- Augmentation of macular pigment and improved visual function are also suggested.
Conclusions:
- The NP-10 System offers a scaffold for investigating nutraceuticals in glaucoma.
- Further large, randomized trials are needed to establish clinical efficacy and safety.
- Targeted nutritional support could become integral to proactive glaucoma care.
Related Concept Videos
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Open Angle Glaucoma: Treatment
938
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
938
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

